Kite Pharma gets Yescarta approval in Japan for large B-cell lymphoma

Kite Pharma, a subsidiary of Gilead Sciences, and Daiichi Sankyo have received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for their ... Read More